4//SEC Filing
ARCA biopharma, Inc. 4
Accession 0001209191-17-015981
$ORKACIK 0000907654operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:11 PM ET
Size
8.8 KB
Accession
0001209191-17-015981
Insider Transaction Report
Form 4
Keuer Thomas A
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2017-02-27+23,800→ 23,800 totalExercise: $2.60Exp: 2027-02-26→ Common Stock (23,800 underlying) - Sale
Common Stock
2017-02-28$2.61/sh−465$1,214→ 14,435 total
Footnotes (3)
- [F1]Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Amended and Restated Equity Incentive Plan (the "Plan").
- [F2]Includes (i) remaining 1,222 previously reported shares issued as RSUs under the Plan that vest on 2/27/18, and (ii) 2,414 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning 4/2/17, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 10,799 previously reported shares of common stock owned.
- [F3]Grant to the Reporting Person of a stock option under the Plan, 50% vesting upon achievement of certain pre-specified corporate milestone related to the outcome of the interim data analysis by that trial's Data and Safety Monitoring Board, and if the milestone is achieved, the remainder of the grant will vest on March 31, 2018, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. If the corporate milestone is not achieved, the Option will be cancelled. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000907654
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:11 PM ET
- Size
- 8.8 KB